FORUM MARKETS Inc (FRMM): Nasdaq/NYSE listing notice — 180 Life Sciences receives Nasdaq delisting notice for bid price non-compliance

FORUM MARKETS Inc

Nasdaq notified on Sept 7, 2023 that ATNF failed minimum bid price of $1.00 for 30 consecutive business days.
Company has until March 5, 2024 (180 days) to regain compliance with closing bid >= $1.00 for 10 consecutive days.
If not compliant by then, an additional 180 days may be granted if company meets other initial listing criteria and intends to cure via reverse stock split.
Company intends to monitor bid price and consider available options to regain compliance.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.98

FORUM MARKETS Inc received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2), 5810(c)(3)(A)

Exact text from the filing

September 7, 2023, 180 Life Sciences Corp. (the “ Company ”, “ we ” or “ us ”) received written notice (the “ Notification Letter ”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”) notifying the Company that it is not in compliance with the minimum bid price requirements set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market. Nasdaq Listing Rule 5550(a)(2) requires listed securities to maintain a minimum bid price of $1.00 per share, and Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid pric

View on SEC.gov

20 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

FORUM MARKETS Inc filing history →

Source: SEC EDGAR

accession 0001213900-23-075412

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.